Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. bras. ortop ; 55(1): 75-81, Jan.-Feb. 2020. tab, graf
Article in English | LILACS | ID: biblio-1092674

ABSTRACT

Abstract Objectives To evaluate the management of tibial fractures resulting in bone loss (traumatic or infection-related) and the complications occurring during treatment with external fixator and immediately after apparatus removal. Methods Forty patients were selected from 2010 to 2017. The mean age of the patients was 33.02 years; 34 subjects were male and 6 were female. All patients had tibial bone regeneration, suffered trauma (mainly related to motorcycle accident) and were followed-up at an outpatient facility. Results Proximal tibial bones of up to 17 cm in length and distal tibial bones of up to 14 cm in length were obtained. The largest trifocal transport had the same length as the regenerated bone tissues, which was 14.5 cm. Regarding complications, 29 (72.5%) patients had infections in the pin and wire paths. There were 9 (22.5%) cases of de novo fracture, 6 of which were managed with the implantation of a new circular fixator, and 2 cases of infection of the regenerated bone. On average, patients were subjected to 4.72 procedures (ranging from 2-12), had the fixator for 20.75 months (ranging from 7-55 months), and stayed at the hospital for 53.7 days (ranging from 5-183 days), mainly because of soft-tissue complications, intravenous antibacterial therapy, and even social issues. Two (5%) patients presented symptomatic gonarthrosis, and two other patients had symptomatic ankle arthritis. Three of the patients showed lower limb discrepancy of 3.0, 3.7, and 5.0 cm. Conclusion Despite not being widely available, the Ilizarov method is useful for solving the majority of tibial bone losses, regardless of their etiology.


Resumo Objetivo Avaliar o tratamento das fraturas de tíbia que evoluíram com perda óssea (traumática ou secundária a infecção) e as complicações ocorridas durante o tratamento com fixador externo e no período imediatamente após sua retirada. Métodos Foram selecionados 40 pacientes tratados entre 2010 e 2017, com a idade média de 33,02 anos, sendo 34 do sexo masculino e 6 do sexo feminino. Todos os pacientes portavam regenerado ósseo da tíbia, foram vítimas de trauma (sobretudo motociclístico), e estavam em seguimento ambulatorial. Resultados Foram obtidos regenerados ósseos da tíbia proximal de até 17 cm e da tíbia distal de 14 cm. O maior transporte trifocal teve a soma do tamanho dos tecidos dos ossos regenerados, medindo 14,5 cm. Como complicações, 29 (72,5%) pacientes tiveram infecção no trajeto dos pinos e fios. Houve 9 (22,5%) casos de refratura, sendo 6 deles tratadas com novo fixador circular, e 2 infecções no osso regenerado. Os pacientes foram submetidos a uma média de 4,72 procedimentos cirúrgicos (2-12), portaram fixador por 20,75 meses (7-55 m.) e permaneceram internados por 53,7 dias (5-183) devido principalmente a complicações de partes moles, a antibioticoterapia intravenosa ou até mesmo a questões sociais. Dois (5%) pacientes apresentaram gonartrose sintomática e outros 2 artrite sintomática do tornozelo. Três apresentaram discrepância de membros inferiores de 3,0; 3,7; e 5,0 cm. Conclusão Apesar de não ser um método de tratamento amplamente disponível, o método de Ilizarov é útil para solucionar a maioria das falhas ósseas da tíbia, independente da sua etiologia.


Subject(s)
Humans , Male , Female , Osteitis , Osteogenesis , Tibia , Bone and Bones , Bone Regeneration , External Fixators , Ilizarov Technique , Fractures, Bone
2.
Rev Assoc Med Bras (1992) ; 66(4): 491-497, 2020. tab, graf
Article in English | SES-SP, LILACS | ID: biblio-1136231

ABSTRACT

SUMMARY BACKGROUND Physiotherapy services are necessary for hospitalized patients of COVID-19 as well as chronic patients. Thus, physiotherapists present an increased risk of exposure to coronavirus. This study aimed to determine the number of physiotherapists who interrupted their services because of the COVID-19 pandemic and to verify the procedures adopted by the ones who are still working. METHODS The sample comprised 619 physiotherapists who worked in Portugal, 154 (24.9%) male and 465 (75.1%) female, aged between 22 and 67 years (34.47±8.70). The measurement instrument was an on-line questionnaire applied in late March 2020 through contacts and social networks. RESULTS 453 (73.2%) physiotherapists interrupted their work activities in person because of the pandemic and 166 (26.8%) continue to work in person. The main measures adopted by physical therapists who continue to work in person included: hand washing (21.5%), mask use (20.3%), material disinfection (19.3%) and, glove use (19.3%). Of the physiotherapists who are not working in person (n = 453), 267 (58.9%) continue to monitor their patients at a distance, and 186 (41.1%) are not monitoring the patients. The main measures used by physiotherapists to monitor their patients at a distance included: written treatment prescription (38%), making explanatory videos (26.7%), and synchronous video conference treatment (23.5%). CONCLUSIONS Our data revealed that most of the physiotherapists interrupted their face-to-face practices because of the COVID-19 pandemic, however, once they do not follow up their patients' treatment in person, most of them adapted to monitor their patients from a distance.


SUMMARY INTRODUÇÃO Os serviços de fisioterapia são necessários para o tratamento de pacientes hospitalizados com COVID-19 e também para pacientes crônicos. Assim, os fisioterapeutas apresentam um maior risco de exposição ao coronavírus. O objetivo deste estudo foi determinar o número de fisioterapeutas que interromperam seus serviços devido à pandemia do COVID-19 e verificar os procedimentos adotados pelos fisioterapeutas que continuam trabalhando. METODOLOGIA A amostra foi constituída por 619 fisioterapeutas, que trabalhavam em Portugal, sendo 154 (24,9%) do sexo masculino e 465 (75,1%) do sexo feminino, com idades compreendidas entre os 22 e 67 anos (34,47 ± 8,70 anos). O instrumento de medida utilizado consistiu num questionário online, tendo sido aplicado em finais de março de 2020, através de contatos e redes sociais. RESULTADOS 453 (73.2%) fisioterapeutas interromperam as suas atividades laborais de forma presencial por causa da pandemia e 166 (26.8%) continuam a trabalhar presencialmente. As principais medidas adotadas pelos fisioterapeutas que continuam a trabalhar presencialmente incluíram: lavagem das mãos (21.5%), uso de máscaras (20.3%), desinfecção do material (19.3%) e uso de luvas (19.3%). Dos fisioterapeutas que não estão a trabalhar presencialmente (n=453), 267 (58.9%) continuam a acompanhar os seus pacientes à distância e 186 (41.1%) não estão a acompanhar os pacientes. As principais medidas utilizadas pelos fisioterapeutas para acompanhar os seus pacientes à distância incluíram: prescrição do tratamento por escrito (38%), realização de vídeos explicativos (26.7%) e tratamento por videoconferência de forma síncrona (23.5%). CONCLUSÕES Os dados do presente estudo revelaram que a maioria dos fisioterapeutas interromperam as suas práticas presenciais em virtude da pandemia COVID-19, no entanto, apesar de não estarem a acompanhar os seus pacientes pessoalmente, a maioria deles elaborou ferramentas para monitorar seus pacientes à distância.


Subject(s)
Humans , Male , Female , Adult , Aged , Young Adult , Pneumonia, Viral/prevention & control , Physical Therapy Modalities/organization & administration , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Physical Therapists/supply & distribution , Betacoronavirus , Portugal , Professional Practice/organization & administration , Professional Practice/trends , Cross-Sectional Studies , Surveys and Questionnaires , Physical Therapy Modalities/trends , Coronavirus Infections , Physical Therapists/trends , Telerehabilitation/organization & administration , Middle Aged
3.
Einstein (Säo Paulo) ; 16(2): eRC4030, 2018. tab, graf
Article in English | LILACS | ID: biblio-953153

ABSTRACT

ABSTRACT Immunotherapy-induced pneumonitis is a rare complication with incidence estimated around 3%. This disease is difficult to diagnose and has great morbidity. For this reason, it became a challenge for oncologists and emergencists. We reviewed the case of five patients who used anti-PD1 (program cell death receptor antagonist 1) for antineoplastic treatment and developed treatment-induced pneumonitis. All patients had respiratory problems because of immunotherapy and presence of ground-glass radiologic change. Among all patients, only one had grade 5 pneumonitis, and delaying to begin corticosteroid therapy and worsening in clinical picture led to patient death. Other four patients with symptomatic grade 2 pneumonitis underwent corticosteroid therapy and had improvement in clinical and radiologic picture. Two patients were treated after an episode of pneumonitis, and no new pulmonary complications were observed until the end of this study. Immunotherapy-induced pneumonitis, although uncommon, can be potentially fatal. Medical team has the responsibility to pay attention for most common symptoms of the disease such as cough and dyspnea and conduct an early diagnosis and effective early treatment with corticosteroids.


RESUMO A pneumonite secundária à imunoterapia é uma complicação rara, com incidência estimada em cerca de 3%. No entanto, trata-se de uma intercorrência de difícil diagnóstico e com grande morbidade, que tem se tornado um desafio para oncologistas e emergencistas. Foram revisados os casos de cinco pacientes que fizeram uso de anti-PD1 (program cell death receptor antagonist 1) para tratamento antineoplásico e que evoluíram com quadro de pneumonite induzida pelo tratamento. Todos os pacientes apresentaram sintomas respiratórios em vigência de tratamento, com imunoterapia e presença de alteração radiológica em vidro fosco. Dentre estes pacientes, apenas um apresentou pneumonite grau 5, com atraso na introdução de corticoidoterapia, indo a óbito em decorrência do quadro. Os outros quatro pacientes apresentaram pneumonite grau 2, sintomática, sendo tratados com corticoidoterapia e evoluindo com melhora clínica e radiológica. Dois pacientes mantiveram o tratamento após o episódio de pneumonite, sem novas complicações pulmonares posteriores, até o momento. A pneumonite induzida por imunoterapia, apesar de ser um evento pouco frequente, pode acarretar grande morbidade, além de ser potencialmente fatal, cabendo à equipe médica ter atenção aos sintomas mais comuns, como tosse e dispneia, para diagnóstico precoce e tratamento efetivo, com uso precoce de corticoide.


Subject(s)
Humans , Male , Aged , Aged, 80 and over , Pneumonia/chemically induced , Antibodies, Monoclonal, Humanized/adverse effects , Immunotherapy/adverse effects , Antibodies, Monoclonal/adverse effects , Antineoplastic Agents/adverse effects , Pneumonia/drug therapy , Pneumonia/diagnostic imaging , Carcinoma/therapy , Adrenal Cortex Hormones/therapeutic use , Fatal Outcome , Antibodies, Monoclonal, Humanized/therapeutic use , Nivolumab , Lung Neoplasms/therapy , Middle Aged , Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use
4.
Rev. med. (Säo Paulo) ; 86(3): 174-184, jul.-set. 2007. tab, graf
Article in Portuguese | LILACS | ID: lil-497271

ABSTRACT

A estenose traqueobrônquica é uma condição que cursa com dispnéia, estridor e pneumonia obstrutiva, causada por diversas condiçoes como tumores, compressão extrínseca e traqueobroncospia, porém a causa. mais frequente é a complicação resultante de intubação prolongada...


Tracheobronchial stenosis curses with dyspnea, stridor and obstructive pneumonia, and can be caused by tumors, extrinsic compression and tracheobronchomalacia, butthe most frequent cause is the sequel resulting of prolonged intubation, occurring in about intubations. The treatment of choice for such condition is resection of the compromise segment; however this procedure isn´t possible in every patient and this led to the development of endoscopic palliative technique. Tracheobronchial stentintg is between one of such techniques that obtain the best results. Tracheobronchial stents can be divided manly between silicone tubes and self-expandable metallic stents, each one with specific advantages and disadvantages. The present study presents the main stent models, comparing their advantages and disadvantages and complications rates, aiming to systematize the ideal indications for every type of stent...


Subject(s)
Constriction, Pathologic , Dyspnea/etiology , Prostheses and Implants , Trachea/surgery , Stents
SELECTION OF CITATIONS
SEARCH DETAIL